Mathematical Modeling of Blood Sugar and Hormone Responses in Insulin-Dependent Type 2 Diabetes
Part of paid clinical trials in Chicago, Illinois.
- Sponsor
- Clinical Nutrition Research Center, Illinois Institute of Technology
- Study ID
- NCT07650682
- Status
- Recruiting
Conditions
- Insulin Dependent Diabetes
- Type 2 Diabetes
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - 65 Years
- Healthy Volunteers
- Not accepted
Study Details
This observational study aims to collect detailed metabolic and physiologic data from adults with insulin-dependent type 2 diabetes mellitus following consumption of a mixed meal tolerance test. Participants will undergo frequent blood sampling over a 4-hour period after consuming a standardized liquid mixed meal to measure glucose, insulin, glucagon, C-peptide, and triglyceride responses. Participants will also use continuous glucose monitoring and wearable physical activity tracking devices during free-living conditions. The purpose of this study is to develop mathematical models and digital representations ("digital twins") of people with type 2 diabetes mellitus. These models may help researchers better understand metabolic responses to meals, physical activity, and diabetes treatments, and may support future development of personalized diabetes technologies and therapies.
Key Dates
- Start date
- May 20, 2026
- Status verified
- Jun 2026
- Primary completion
- Oct 20, 2026
- Completion
- Mar 20, 2027
Study Design
- Enrollment
- 25 participants (estimated)
Arms
- Arm: Adults With Insulin-Dependent Type 2 Diabetes MellitusAdults 18 to 65 years of age with insulin-dependent type 2 diabetes mellitus who will undergo a liquid meal tolerance test with frequent blood sampling over 4 hours following consumption of a standardized liquid meal. Participants will also undergo outpatient continuous glucose monitoring and wearable physical activity tracking during free-living conditions to support mathematical modeling of metabolic and physiologic responses.
Primary Outcome Measure
Change in Plasma Glucose Concentration (mg/dL) [ Time Frame: -10 to 240 minutes relative to meal consumption ]
Central Contacts
- Chelsea Preiss, Clinical Research Manager, MS312-567-5300
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Illinois Institute of Technology | Chicago | Illinois | 60616 | Indika Edirisinghe, PhD (PRINCIPAL_INVESTIGATOR) |
Find similar trials in Chicago, IL
Related Studies
- My ESSENCE - A Research Study on Mindfulness for African-Americans With Type 2 DiabetesRecruiting · University of Illinois at Chicago · Chicago, Illinois
- Safety and Effectiveness of Endoscopic Intestinal Re-Cellularization Therapy in Individuals With Type II DiabetesRecruiting · Endogenex, Inc. · Birmingham, Alabama
- A Study of Dulaglutide (LY2189265) 3.0 mg and 4.5 mg in Pediatric Participants With Type 2 Diabetes Mellitus (AWARD-PEDS PLUS)PHASE3 · Recruiting · Eli Lilly and Company · Tucson, Arizona
- Enhancing Diabetes Care: Exposome &Amp; SensorsRecruiting · University of Illinois at Chicago · Chicago, Illinois